Menu
Currency
GWAS Study

Novel ancestry-specific primary open-angle glaucoma loci and shared biology with vascular mechanisms and cell proliferation.

Lo Faro V, Bhattacharya A, Zhou W et al.

38382466 PubMed ID
GWAS Study Type
1478037 Participants
107 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LF
Lo Faro V
BA
Bhattacharya A
ZW
Zhou W
ZD
Zhou D
WY
Wang Y
LK
Läll K
KM
Kanai M
LE
Lopera-Maya E
SP
Straub P
PP
Pawar P
TR
Tao R
ZX
Zhong X
NS
Namba S
SS
Sanna S
NI
Nolte IM
OY
Okada Y
IN
Ingold N
MS
MacGregor S
SH
Snieder H
SI
Surakka I
SJ
Shortt J
GC
Gignoux C
RN
Rafaels N
CK
Crooks K
VA
Verma A
VS
Verma SS
GL
Guare L
RD
Rader DJ
WC
Willer C
MA
Martin AR
BM
Brantley MA
GE
Gamazon ER
JN
Jansonius NM
JK
Joos K
CN
Cox NJ
HJ
Hirbo J
Chapter II

Abstract

Summary of the research findings

Primary open-angle glaucoma (POAG), a leading cause of irreversible blindness globally, shows disparity in prevalence and manifestations across ancestries. We perform meta-analysis across 15 biobanks (of the Global Biobank Meta-analysis Initiative) (n = 1,487,441: cases = 26,848) and merge with previous multi-ancestry studies, with the combined dataset representing the largest and most diverse POAG study to date (n = 1,478,037: cases = 46,325) and identify 17 novel significant loci, 5 of which were ancestry specific. Gene-enrichment and transcriptome-wide association analyses implicate vascular and cancer genes, a fifth of which are primary ciliary related. We perform an extensive statistical analysis of SIX6 and CDKN2B-AS1 loci in human GTEx data and across large electronic health records showing interaction between SIX6 gene and causal variants in the chr9p21.3 locus, with expression effect on CDKN2A/B. Our results suggest that some POAG risk variants may be ancestry specific, sex specific, or both, and support the contribution of genes involved in programmed cell death in POAG pathogenesis.

21,839 European, African, Central/South Asian, East Asian or Hispanic cases, 1,237,201 European, African, Central/South Asian, East Asian or Hispanic controls, 15,229 European ancestry cases, 177,473 European ancestry controls, 9,257 African ancestry cases, 17,038 African ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1478037
Total Participants
GWAS
Study Type
No
Replicated
European, African unspecified, Central Asian, South Asian, East Asian, Hispanic or Latin American, European, African unspecified
Ancestry
Canada, Netherlands, U.S., Norway, China, Japan, Finland, U.K., Australia, Iceland, Estonia
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.